Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable.
Leebeek
F W G
FW
Department of Hematology, Erasmus University Medical Center Rotterdam, The Netherlands.
Boersma
E
E
Cannon
C P
CP
van de Werf
F J J
FJ
Simoons
M L
ML
D000284:Administration, Oral; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex